CurveBeam AIASX:CVB FCF Yield % is -79.98 as of Jun. 26, 2026. The stock has 5 warning signs investors should review. Among 855 Medical Devices & Instruments companies, CurveBeam AI ranks worse than 94.39% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for CurveBeam AI's FCF Yield % or its related term are showing as below:
ASX:CVB'
s FCF Yield % Range Over the Past 10 Years
Min: -242.83 Med: -61.88 Max: -18.29
Current: -79.98
During the past 5 years, the highest FCF Yield % of CurveBeam AI was -18.29%. The lowest was -242.83%. And the median was -61.88%.
ASX:CVB's FCF Yield % is ranked worse than 94.39% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs ASX:CVB: -79.98
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
CurveBeam AI FCF Yield % Related Terms
CurveBeam AI FCF Yield % Historical Data
* Premium members only.
The historical data trend for CurveBeam AI's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CurveBeam AI's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's FCF Yield % distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CurveBeam AI (ASX:CVB) has a FCF Yield % of -79.98 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on CurveBeam AI and its competitors. According to the industry distribution chart, CurveBeam AI ranks #807 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 94.4%.
Is CurveBeam AI's FCF Yield % too high?
CurveBeam AI's current FCF Yield % is -79.98. Based on the distribution chart, CurveBeam AI ranks #807 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does CurveBeam AI's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #807 out of 855 companies for FCF Yield %. This places CurveBeam AI in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current FCF Yield % is -79.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current FCF Yield % of -79.98. The current FCF Yield % is -79.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current FCF Yield % is -79.98 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CVB has been successfully added to your 